Elanco In-feed BRD Therapy Drug Approved By FDA
December 1, 2011
The U.S. Food and Drug Administration approved Elanco’s new in-feed antimicrobial, Pulmotil (tilmicosin), for treatment of Bovine Respiratory Disease in groups of cattle in the early stages of a BRD outbreak, the company reported today. The FDA approved Pulmotil...